These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25694895)

  • 21. Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article.
    Davis RJ; Kim KD; Hisey MS; Hoffman GA; Bae HW; Gaede SE; Rashbaum RF; Nunley PD; Peterson DL; Stokes JK
    J Neurosurg Spine; 2013 Nov; 19(5):532-45. PubMed ID: 24010901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of disabling single-level lumbar discogenic low back pain with total disc arthroplasty utilizing the Prodisc prosthesis: a prospective study with 2-year minimum follow-up.
    Bertagnoli R; Yue JJ; Shah RV; Nanieva R; Pfeiffer F; Fenk-Mayer A; Kershaw T; Husted DS
    Spine (Phila Pa 1976); 2005 Oct; 30(19):2230-6. PubMed ID: 16205353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lumbar spine arthroplasty using the ProDisc II.
    Zigler JE
    Spine J; 2004; 4(6 Suppl):260S-267S. PubMed ID: 15541675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part II: evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes.
    McAfee PC; Cunningham B; Holsapple G; Adams K; Blumenthal S; Guyer RD; Dmietriev A; Maxwell JH; Regan JJ; Isaza J
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1576-83; discussion E388-90. PubMed ID: 16025025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total disc replacement versus multidisciplinary rehabilitation in patients with chronic low back pain and degenerative discs: 8-year follow-up of a randomized controlled multicenter trial.
    Furunes H; Storheim K; Brox JI; Johnsen LG; Skouen JS; Franssen E; Solberg TK; Sandvik L; Hellum C
    Spine J; 2017 Oct; 17(10):1480-1488. PubMed ID: 28583869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of lumbar degenerative disc disease treated with posterior lumbar interbody fusion allograft spacer: a prospective, multicenter trial with 2-year follow-up.
    Arnold PM; Robbins S; Paullus W; Faust S; Holt R; McGuire R
    Am J Orthop (Belle Mead NJ); 2009 Jul; 38(7):E115-22. PubMed ID: 19714280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of patients who have undergone 1-Level versus 2-Level ProDisc arthroplasty: a prospective study with minimum of 5-year follow-up.
    Yue J; Zhang K; Bai HX; Du J; Cammisa F; Abjornson C; Mo F
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1194-8. PubMed ID: 23392415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study.
    Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M
    Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical results with ProDisc: European experience and U.S. investigation device exemption study.
    Zigler JE
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S163-6. PubMed ID: 14560187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lumbar total disc arthroplasty in patients older than 60 years of age: a prospective study of the ProDisc prosthesis with 2-year minimum follow-up period.
    Bertagnoli R; Yue JJ; Nanieva R; Fenk-Mayer A; Husted DS; Shah RV; Emerson JW
    J Neurosurg Spine; 2006 Feb; 4(2):85-90. PubMed ID: 16506473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision making in surgical treatment of chronic low back pain: the performance of prognostic tests to select patients for lumbar spinal fusion.
    Willems P
    Acta Orthop Suppl; 2013 Feb; 84(349):1-35. PubMed ID: 23427903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting reoperations after anterior cervical discectomy and fusion within and outside of a Federal Drug Administration investigational device exemption cervical disc replacement trial.
    Singh K; Phillips FM; Park DK; Pelton MA; An HS; Goldberg EJ
    Spine J; 2012 May; 12(5):372-8. PubMed ID: 22425784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease: 7-Year Results.
    Radcliff K; Zigler J; Braxton E; Buttermann G; Coric D; Derman P; Garcia R; Jorgensen A; Ferko NC; Situ A; Yue J
    Int J Spine Surg; 2021 Aug; 15(4):612-632. PubMed ID: 34266934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MOS short form 36 and Oswestry Disability Index outcomes in lumbar fusion: a multicenter experience.
    Glassman S; Gornet MF; Branch C; Polly D; Peloza J; Schwender JD; Carreon L
    Spine J; 2006; 6(1):21-6. PubMed ID: 16413443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 2 lumbar total disc replacements: results of a prospective, randomized, controlled, multicenter Food and Drug Administration trial with 24-month follow-up.
    Guyer RD; Pettine K; Roh JS; Dimmig TA; Coric D; McAfee PC; Ohnmeiss DD
    Spine (Phila Pa 1976); 2014 May; 39(12):925-31. PubMed ID: 24718066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ProDisc-C Total Disc Replacement Versus Anterior Cervical Discectomy and Fusion for Single-Level Symptomatic Cervical Disc Disease: Seven-Year Follow-up of the Prospective Randomized U.S. Food and Drug Administration Investigational Device Exemption Study.
    Janssen ME; Zigler JE; Spivak JM; Delamarter RB; Darden BV; Kopjar B
    J Bone Joint Surg Am; 2015 Nov; 97(21):1738-47. PubMed ID: 26537161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-center, prospective, randomized, controlled investigational device exemption clinical trial comparing Mobi-C Cervical Artificial Disc to anterior discectomy and fusion in the treatment of symptomatic degenerative disc disease in the cervical spine.
    Hisey MS; Bae HW; Davis R; Gaede S; Hoffman G; Kim K; Nunley PD; Peterson D; Rashbaum R; Stokes J
    Int J Spine Surg; 2014; 8():. PubMed ID: 25694918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiological and clinical outcomes following extreme lateral interbody fusion.
    Alimi M; Hofstetter CP; Cong GT; Tsiouris AJ; James AR; Paulo D; Elowitz E; Härtl R
    J Neurosurg Spine; 2014 Jun; 20(6):623-35. PubMed ID: 24702513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dynamic neutralization using the Dynesys system for treatment of degenerative disc disease of the lumbar spine].
    Cienciala J; Chaloupka R; Repko M; Krbec M
    Acta Chir Orthop Traumatol Cech; 2010 Jun; 77(3):203-8. PubMed ID: 20619111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurological complications of lumbar artificial disc replacement and comparison of clinical results with those related to lumbar arthrodesis in the literature: results of a multicenter, prospective, randomized investigational device exemption study of Charité intervertebral disc. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Geisler FH; Blumenthal SL; Guyer RD; McAfee PC; Regan JJ; Johnson JP; Mullin B
    J Neurosurg Spine; 2004 Sep; 1(2):143-54. PubMed ID: 15346999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.